News and Events

RNA Therapeutics Symposium

Unlocking the RNA’s Potential in Medicine, scheduled to take place from September 25-27, 2024, in the beautiful city of Porto, Portugal

Read More
CANCERNA Partners held a face-to-face meeting on September 5-6, 2022 meeting in Jerusalem
Read More
Breakthrough RNA-Based Anti-Cancer Immunotherapy Treatments Being Developed by Global Consortium led by the Hadassah Cancer Research Institute
Read More
HADASSAH AND DRUG GIANT MERCK LAUNCH MRNA INITIATIVE TO FIGHT CANCER
Read More
Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine
Read More
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
Read More
CANCERNA's 2nd Yearly Meeting: Driving Advancements in RNA Processing for Anti-Cancer Immunotherapy
Read More
CanceRNA Hosts Its 2nd Annual Meeting Focusing on RNA-Based Cancer Therapies at CRG, Barcelona
Read More
Welcome Letter from Prof. Carmo Fonseca, Chair of the RNA Horizons Conference Scientific Committee
Read More
Quick Link
footer_logo

Funded by the European Union. Views and opinions expressed are however those of the author(s) only
and do not necessarily reflect those of the European Union or HADEA. Neither
the European Union nor the granting authority can be held responsible for them.

Contact Info
Copyright © 2025 all rights reserved
Skip to content